Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase
- PMID: 15019741
- DOI: 10.1016/S0378-1097(04)00038-2
Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase
Abstract
The gene for dihydrofolate reductase of Mycobacterium tuberculosis was amplified by polymerase chain reaction (PCR) from M. tuberculosis H37Rv strain genomic DNA. The protein was expressed in inclusion bodies in high yield in Escherichia coli under the control of the T7 promoter. Active enzyme was obtained by refolding from guanidine HCl and after a single chromatography step the sample was > 99% homogeneous with a specific activity of approximately 15.5 micromol min(-1) mg(-1). Mass spectrometry analysis confirmed the expected mass of 17.6 kDa. Gel filtration of the enzyme indicated that it was a monomer. Steady-state kinetic parameters were determined and the effect of pH and KCl on the enzyme examined. Methotrexate and trimethoprim inhibited the enzyme.
Similar articles
-
Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.Protein Expr Purif. 1993 Feb;4(1):16-23. doi: 10.1006/prep.1993.1003. Protein Expr Purif. 1993. PMID: 8425104
-
Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein.Protein Expr Purif. 1996 Aug;8(1):23-7. doi: 10.1006/prep.1996.0070. Protein Expr Purif. 1996. PMID: 8812831
-
Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.Biochemistry. 1996 May 21;35(20):6366-74. doi: 10.1021/bi952923q. Biochemistry. 1996. PMID: 8639582
-
Integron-sequestered dihydrofolate reductase: a recently redeployed enzyme.Trends Microbiol. 2006 May;14(5):236-42. doi: 10.1016/j.tim.2006.03.003. Epub 2006 Apr 3. Trends Microbiol. 2006. PMID: 16584884 Review.
-
In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria.J Chemother. 1993 Dec;5(6):422-9. J Chemother. 1993. PMID: 8195833 Review.
Cited by
-
Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.ACS Med Chem Lett. 2015 Oct 17;6(11):1140-4. doi: 10.1021/acsmedchemlett.5b00367. eCollection 2015 Nov 12. ACS Med Chem Lett. 2015. PMID: 26617968 Free PMC article.
-
Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.Antimicrob Agents Chemother. 2015 Sep;59(9):5097-106. doi: 10.1128/AAC.00647-15. Epub 2015 Jun 1. Antimicrob Agents Chemother. 2015. PMID: 26033719 Free PMC article. Review.
-
In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery.Mol Divers. 2010 Aug;14(3):595-604. doi: 10.1007/s11030-009-9172-6. Epub 2009 Aug 21. Mol Divers. 2010. PMID: 19697148
-
Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.Biochemistry. 2016 Feb 23;55(7):1107-19. doi: 10.1021/acs.biochem.5b00993. Epub 2016 Feb 5. Biochemistry. 2016. PMID: 26848874 Free PMC article.
-
Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR.RSC Med Chem. 2020 Oct 22;12(1):103-109. doi: 10.1039/d0md00303d. eCollection 2021 Jan 1. RSC Med Chem. 2020. PMID: 34046602 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous